Mineji Hayakawa Selected Research

AIDS-Related Complex (ARC)

3/2023	Onset timing and duration of augmented renal clearance in a mixed intensive care unit.
2/2022	Clinical applicability of urinary creatinine clearance for determining the initial dose of vancomycin in critically ill patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mineji Hayakawa Research Topics

Disease

51	Disseminated Intravascular Coagulation 05/2024 - 01/2003
38	Sepsis (Septicemia) 05/2024 - 08/2002
25	Wounds and Injuries (Trauma) 01/2024 - 12/2002
16	Thrombosis (Thrombus) 04/2024 - 12/2002
16	Hemorrhage 01/2024 - 11/2009
15	Critical Illness (Critically Ill) 04/2024 - 07/2006
14	Septic Shock (Toxic Shock Syndrome) 01/2023 - 08/2002
11	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 05/2024 - 08/2002
11	Multiple Organ Failure (MODS) 01/2016 - 08/2002
9	Heart Arrest (Cardiac Arrest) 01/2023 - 05/2008
8	Out-of-Hospital Cardiac Arrest 08/2021 - 05/2008
7	Inflammation (Inflammations) 04/2024 - 12/2002
7	Hypothermia 02/2024 - 03/2016
7	COVID-19 12/2023 - 08/2021
7	Shock 12/2020 - 05/2009
2	Hypoxia (Hypoxemia) 01/2024 - 07/2011
2	Pneumonia (Pneumonitis) 10/2023 - 01/2022
2	AIDS-Related Complex (ARC) 03/2023 - 02/2022
2	Post-Cardiac Arrest Syndrome 01/2023 - 08/2021
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 08/2017
2	Lung Injury 01/2022 - 01/2010
2	Respiratory Insufficiency (Respiratory Failure) 01/2019 - 10/2017
2	Hypotension (Low Blood Pressure) 08/2017 - 03/2016
2	Acidosis 09/2016 - 03/2016
2	Body Weight (Weight, Body) 01/2015 - 12/2008
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2010 - 01/2003
1	Acute Kidney Injury (Acute Renal Failure) 03/2024
1	Tics (Tic) 12/2023
1	Lung Diseases (Lung Disease) 08/2023
1	Central Nervous System Diseases (CNS Diseases) 03/2023
1	Hyperlactatemia 01/2023
1	Obesity 01/2023
1	Hyperoxia 01/2023
1	Acute Lung Injury 01/2023

Drug/Important Bio-Agent (IBA)

51	Dacarbazine (DIC)FDA LinkGeneric 05/2024 - 08/2002
14	ThrombomodulinIBA 01/2022 - 12/2002
12	AntithrombinsIBA 09/2018 - 12/2006
11	AnticoagulantsIBA 05/2024 - 06/2012
11	Fibrinogen (Factor I)FDA Link 03/2021 - 12/2006
10	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2012 - 08/2002
8	FibrinIBA 09/2016 - 01/2007
6	formycin diphosphate (FDP)IBA 08/2021 - 01/2007
6	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2007
5	Plasminogen Activators (Plasminogen Activator)IBA 10/2021 - 01/2007
5	Fibrin Fibrinogen Degradation ProductsIBA 08/2021 - 01/2007
5	Thromboplastin (Tissue Factor)IBA 07/2013 - 08/2002
4	IceIBA 02/2024 - 10/2021
4	Blood Coagulation Factors (Coagulation Factor)IBA 12/2023 - 07/2011
4	Hemostatics (Antihemorrhagics)IBA 01/2022 - 07/2011
4	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2020 - 11/2009
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2024 - 02/2011
3	Heparin (Liquaemin)FDA LinkGeneric 11/2023 - 01/2016
3	Indicators and Reagents (Reagents)IBA 08/2023 - 03/2016
3	CreatinineIBA 03/2023 - 01/2015
3	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2021 - 02/2011
3	Protein CIBA 01/2016 - 01/2007
3	Thrombin FDA Link 03/2015 - 07/2011
3	Fibrinolysin FDA Link 12/2012 - 01/2007
3	Antithrombin IIIIBA 10/2009 - 12/2006
2	Tranexamic Acid (AMCA)FDA Link 12/2023 - 07/2011
2	Vasopressins (Vasopressin)IBA 01/2023 - 01/2021
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2022
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023 - 01/2021
2	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2023 - 06/2017
2	Histones (Histone)IBA 08/2022 - 06/2022
2	Proteins (Proteins, Gene)FDA Link 08/2022 - 06/2022
2	Plasminogen Activator Inhibitor 1IBA 10/2021 - 01/2007
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017 - 06/2010
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2015 - 01/2013
2	estropipate (Ogen)FDA LinkGeneric 07/2013 - 07/2011
2	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 12/2012 - 02/2011
2	Macrophage Migration-Inhibitory FactorsIBA 06/2011 - 08/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008 - 08/2007
2	urinastatin (MR 20)IBA 05/2008 - 01/2007
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2005 - 12/2002
2	SelectinsIBA 01/2005 - 12/2002
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2005 - 12/2002
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2003 - 08/2002
1	ChloridesIBA 03/2024
1	ciclesonide FDA Link 12/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023
1	SteroidsIBA 12/2023
1	Hemoglobins (Hemoglobin)IBA 07/2023
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2023
1	edoxabanIBA 01/2023
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2023
1	CatecholaminesIBA 01/2023
1	EndotoxinsIBA 01/2023

Therapy/Procedure

16	Therapeutics 05/2024 - 01/2016
7	Critical Care (Surgical Intensive Care) 02/2024 - 04/2015
6	Cardiopulmonary Resuscitation (CPR) 08/2021 - 05/2009
4	Rewarming 02/2024 - 10/2021
4	Extracorporeal Membrane Oxygenation 02/2024 - 10/2017
4	Resuscitation 01/2024 - 03/2016
4	Artificial Respiration (Mechanical Ventilation) 08/2023 - 08/2013
2	Erythrocyte Transfusion 01/2024 - 07/2023
2	Mechanical Ventilators (Ventilator) 01/2023 - 01/2022
2	Continuous Renal Replacement Therapy 05/2009 - 07/2006
1	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2024